Despite significant insider buying, Biogen's performance las...

Despite significant insider buying, Biogen's performance last year was worse than the annualised loss of 6% over the last half decade. Investors are advised to ensure they are buying a high quality business, as Biogen is showing 2 warning signs in investment analysis.